文献速递肝病

改善饮食质量与肝脏脂肪减少相关,尤其在非酒精性脂肪性肝病高遗传风险评分个体中

Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease.
PubMed 文献 · Gastroenterology · 2018-03-29

在Framingham心脏研究1521名参与者中,前瞻性分析显示地中海式饮食评分(MDS)和替代健康饮食指数(AHEI)每增加1个标准差,肝脏脂肪减少且新发脂肪肝风险分别降低26%和21%,高遗传风险者改善饮食后肝脏脂肪积累减少。

要点

  • MDS每增加1个标准差,LPR增加0.57(95%CI 0.27-0.86),新发脂肪肝风险降低26%。
  • AHEI每增加1个标准差,LPR增加0.56(95%CI 0.29-0.84),新发脂肪肝风险降低21%。
  • 高遗传风险评分者仅在饮食评分下降时肝脏脂肪积累增加,饮食稳定或改善者无此关联。

核心结论

  • 基于MDS和AHEI评分,改善饮食质量与较少的肝脏脂肪积累及新发脂肪肝风险降低相关。
  • 改善饮食对非酒精性脂肪性肝病高遗传风险个体尤为重要。

研究设计与样本

  • 前瞻性研究纳入Framingham心脏研究第二代队列第七和第八次检查(1998-2001年和2005-2008年)或第三代队列第一次和第二次检查(2002-2005年和2008-2011年)的1521名参与者。
  • 采用自填半定量126项哈佛食物频率问卷评估检查前一年膳食摄入。
  • 通过计算机断层扫描图像的肝脏模体比(LPR)评估2002-2005年和2008-2011年肝脏脂肪水平,LPR值与肝脏脂肪呈反向关系。

主要发现

  • MDS每增加1个标准差,LPR增加0.57(95%CI 0.27-0.86;P < .001),新发脂肪肝风险降低26%(95%CI 10%-39%;P = .002)。
  • AHEI每增加1个标准差,LPR增加0.56(95%CI 0.29-0.84;P < .001),新发脂肪肝风险降低21%(95%CI 5%-35%;P = .02)。
  • 饮食评分增加还与较晚期脂肪肝发生风险降低相关。
  • 较高遗传风险评分与肝脏脂肪积累增加相关,见于MDS下降(P < .001)或AHEI评分下降(P = .001)的参与者,但在饮食评分稳定或改善的参与者中无此关联(基因-饮食交互P < .001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Dietary modification has been recommended for treatment of nonalcoholic fatty liver disease (NAFLD), although it is not clear whether improving diet quality can prevent its development. We performed a prospective study to examine the association between diet quality change and change in liver fat. We also examined the association between genetic risk score and liver fat change in individuals with different levels of diet quality change. METHODS: Our study included 1521 participants who attended the seventh and eighth examinations (1998-2001 and 2005-2008) of the second-generation cohort or attended the first and second examinations (2002-2005 and 2008-2011) of the third-generation cohort in the Framingham Heart Study. The self-administered semiquantitative 126-item Harvard food frequency questionnaire was used to determine dietary intake in the year leading up to an examination. We assessed levels of liver fat using liver-phantom ratio (LPR) on computed tomography images from 2002 through 2005 and again from 2008 through 2011. LPR values are inversely related to liver fat: increased LPR indicates decreased liver fat. We examined associations of changes in 2 diet scores, the Mediterranean-style diet score (MDS) and Alternative Healthy Eating Index (AHEI), with changes in liver fat and new-onset fatty liver. We evaluated interactions between diet score change and a weighted genetic risk score for NAFLD, determined based on multiple single-nucleotide polymorphisms identified in genome-wide association studies of NAFLD. The primary outcome was change in LPR between baseline and follow-up measurement. RESULTS: For each 1 standard deviation increase in MDS, the LPR increased (meaning liver fat decreased) by 0.57 (95% confidence interval [CI] 0.27-0.86; P < .001) and the odds for incident fatty liver decreased by 26% (95% CI 10%-39%; P = .002). For each 1 standard deviation increase in AHEI, LPR increased by 0.56 (95% CI 0.29-0.84; P < .001) and the odds for incident fatty liver decreased by 21% (95% CI 5%-35%; P = .02). Increased diet scores were also associated with reduced odds of developing more-advanced fatty liver. Higher genetic risk scores were associated with increased liver fat accumulation in participants who had decreased MDS (P < .001) or AHEI scores (P = .001), but not in those with stable or improved diet scores (P for gene-diet interaction <.001). CONCLUSIONS: In an analysis of participants in the Framingham Heart Study, increasing diet quality, determined based on MDS and AHEI scores, is associated with less liver fat accumulation and reduced risk for new-onset fatty liver. An improved diet is particularly important for individuals with a high genetic risk for NAFLD.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Ma J, Hennein R, Liu C, et al. Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease. Gastroenterology. 2018. PMID: 29604292. doi:10.1053/j.gastro.2018.03.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。